Stempeutics gets DCGI nod for phase-III clinical trial on its product for treating COVID patients
The company will be using its stem cell product, Stempeucel, for conducting the label extension phase-III clinical trial
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Acute Respiratory Distress Syndrome
Biocon presents key Insights into clinical study that enabled DCGI approval of Itolizumab
A multi-centric, open label, two-arm randomized pivotal clinical trial was conducted in 30 eligible patients at four hospitals…
Immune Regulation and DynPort Vaccine Company partner to advance COVID-19 drug in clinical trials
Immune Regulation’s drug candidate IRL201104 has been shown to quickly and markedly reduce excessive infiltration of neutrophils…
Shiv Nadar University develops molecule with potential to cure COVID-19
The molecule has the potential to be developed into a drug that can cure Acute Respiratory Distress Syndrome (ARDS) in COVID-19…